Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NAGS Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA543666
Description
Peptide sequence: YLDKFVVSSS RQGQGSGQML WECLRRDLQT LFWRSRVTNP INPWYFKHSD Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 86%; Horse: 100%; Human: 100%; Mouse: 100%; Pig: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 86%.
NAGS is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.The N-acetylglutamate synthase gene encodes a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. This gene may regulate ureagenesis by altering NAG availability and, thereby, CPSI activity. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.
Specifications
| NAGS | |
| Polyclonal | |
| Unconjugated | |
| NAGS | |
| 1700120E20Rik; AGAS; Amino-acid acetyltransferase; amino-acid N-acetyltransferase; ARGA; LOW QUALITY PROTEIN: N-acetylglutamate synthase, mitochondrial; MGC133025; N-acetylglutamate synthase; N-acetylglutamate synthase conserved domain form; N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase, conserved domain form; N-acetylglutamate synthase, mature form; N-acetylglutamate synthase, mitochondrial; Nags; NAGS-C; NAGS-M; RGD1565783 | |
| Rabbit | |
| Protein A | |
| RUO | |
| 162417 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 2% sucrose and 0.09% sodium azide | |
| Q8N159 | |
| NAGS | |
| Synthetic peptide directed towards the C-terminal of human NAGS (aa 441-490). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction